Trials / Completed
CompletedNCT00137072
Mild To Moderate Erectile Dysfunction Study
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study of Men With Mild to Moderate Erectile Dysfunction to Evaluate the Efficacy of Viagra 8 Hours Post-Dose
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 355 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Safety/Efficacy of 100-mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viagra (Sildenafil Citrate) 100 mg |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-02-01
- First posted
- 2005-08-29
- Last updated
- 2021-02-01
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00137072. Inclusion in this directory is not an endorsement.